We studied the review article about How I investigate eosinophilia, which was published in the International Journal of Laboratory Hematology in August 2018. This paper has clearly and simply introduced how clinicians investigate eosinophilia. Hopefully, it can be helpful to everyone who interested in this field.
We studied the review article about How I investigate eosinophilia, which was published in the International Journal of Laboratory Hematology in August 2018. This paper has clearly and simply introduced how clinicians investigate eosinophilia. Hopefully, it can be helpful to everyone who interested in this field.
There are several important changes in the WHO 5th edition hemato-lymphoid with a paradigm shift towards genetic diagnosis along with morphological aspects. Precursor lesions of Clonal hematopoiesis, CHIP and CCUS are formally included, Changes include those in AML, MPN, JMML is now a part of MPN, MDS-MPN, ALAL etc.
The angiogenesis process, the factors regulating it, different assays for it, a little about tumour angiogenesis, the drugs and new therapeutic approaches towards inhibiting or augmenting the process.
Plasma cell disorders is a difficult topic where most residents and students confuse with regarding to differentiating between various types of para-proteinemias or plasma cell dyscrasias. This simple presentation will highlight the key points in differentiating, diagnosing these orders. Initial management principles are discussed as well.
There are several important changes in the WHO 5th edition hemato-lymphoid with a paradigm shift towards genetic diagnosis along with morphological aspects. Precursor lesions of Clonal hematopoiesis, CHIP and CCUS are formally included, Changes include those in AML, MPN, JMML is now a part of MPN, MDS-MPN, ALAL etc.
The angiogenesis process, the factors regulating it, different assays for it, a little about tumour angiogenesis, the drugs and new therapeutic approaches towards inhibiting or augmenting the process.
Plasma cell disorders is a difficult topic where most residents and students confuse with regarding to differentiating between various types of para-proteinemias or plasma cell dyscrasias. This simple presentation will highlight the key points in differentiating, diagnosing these orders. Initial management principles are discussed as well.
Hemo: Referring to blood cells
Poiesis: “The development or production of”
The word Hemopoiesis refers to the production & development of all the blood cells
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Hematopoiesis
A hematopoietic stem cell is multipotent, or pluripotent, able to differentiate in various ways and thereby generate erythrocytes, granulocytes, monocytes, mast cells, lymphocytes, and megakaryocytes. In hematopoiesis, a multipotent stem cell differentiates along with one of two pathways giving rise to either a common lymphoid progenitor cell or a common myeloid progenitor cell.
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer with a high mortality rate.
Other name: hepatoma
HCC often develops in patients with chronic liver disease
Hepatoblastoma is a disease in which malignant (cancer) cells form in the tissues of the liver. It
is the most common type of childhood liver cancer and usually affects children younger than 3 years of age
the RBC production and maturation completed in the bone marrow normally, all the maturation stages of erythropoiesis are descriped here and how regulated ..etc
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Blood cell production in adult.ppt
1. Developed by Dr.
Abdulrazzak Othman Alagbare
Clinical Pathologist -Hematology Lecturer _ MD
Blood cells production
Hematopoiesis –in adult
2. Hematopoiesis –in adult
Introduction
Hematopoiesis is a term describing the formation and
development of blood cells.
Cells of the blood are constantly being lost or
destroyed.
Thus, to maintain homeostasis, the system must have
the capacity for self renewal.
This system involves:
a) Proliferation of progeny stem cells
b) Differentiation and maturation of the stem cells into
the functional cellular elements.
3.
Types of hematopoiesis
Intramedullary hematopoiesis. It is normal and
occur only in the bone marrow
Extramedullary hematopoiesis. describes
hematopoiesis outside the bone marrow
environment, primarily the liver and spleen. (it is
abnormal)
===========================
Extramedullary hematopoiesis may occur in fetal
hematopoietic tissue (liver and spleen) of an adult when
the bone marrow cannot meet the physiologic needs of
the tissues
Types of hematopoiesis
4. introduction
Blood cells production called hematopoiesis.
1-The main organs for hematopoies in all human life
are
1. Liver and Spleen (prenatal period)
2. And the bone marrow(BM) (adult period)
2-The secondary hematopoietic organ called the
reticuloendothelia system (RES)
The first cell which produce all the other cells
called Pluripotent stem cells (PSC) or
hemocytoblasts
Blood cells production
5. The stem cells
Definition: They are cells which give new generation of
cells, and existing in the bone marrow exclusively and
they are:
The sources of the hematopoietic stem ells are the
mesenchymal ells of the yolk sac and they are
1-Pluripotent stem cells (PSC) or hemohistoblast
2-Myeloid stem cell (MSC)
3-Lymphoid stem cell (LSC)
MSC and LSC also called
Progenitor cells,
Committed cells
or hematopoietic cells
6. Pluripotent stem cells (PSC) or
(hemohistoblast)
Properties
Pluripotent stem cells has the
following properties
1- Self-renewal Has the ability to
renew its selves
2-Multipotentiality Can produce
another cells (pluripotent cells )
3-Mothers of all blood cells
4-Existing mainly in the bone marrow
7.
8. Progenitor cells
What are progenitor cells?
They also called: hematopoietic or
committed cells
They are the first cells which produce
from the stem cell
They are two
1-Myeloid stem cell (MSC)
2- Lymphoid stem cell (LSC)
9. Progenitor cells
The myeloid stem cell
1.Exist in the bone marrow
2.Produce the cells called Myeloid group
or myeloid sera
The lymphoid stem cell
1.Exist in the bone marrow
2.Produce the cell called Lymphoid group
or Lymphoid sera
10. The myeloid stem cell
The cells which produced from the MSC and
existing in the peripheral blood are
CFU-myeloid stem cell
A. CFU-E
I. Eryhtrocytes
B. CFU-GM
I. Granulocytes
II. Monocytes
C. CFU-M
I. Megakaryocytes (Platelets)
11. Progenitor cells culture
In culture media the progenitor cells are
defined as colony forming unit (CFU).
Each of the CFUs in turn can produce a
colony of one hematopoietic lineage
under appropriate growth conditions
12. Early progenitor cells of myeloid
group
7/1/2023
1
2
CFU-E (erythrocytes)
CFU-Meg (megakaryocyte)
CFU-Eo –Bas (Eosinophil and Basophil)
CFU-GM (Granular and monocytes
13. The lymphoid stem cell
The cells which produced from the LSC
and existing in the peripheral blood are
I. T Lymphocytes
II. B Lymphocytes
14. Regulation of hematopoiesis
For blood cells production needs regulation and control to
produce adequate cells and no more than the normal needs, for
that there are many factors do that. There should be a balance
between cell production and cell death except at the times of
requirement
They called
Hemopoietic growth factors
Colonies stimulated factors (CSF)
or cytokines
Controlled cell death
Controlled cell production
15. Haemopoietic growth
factors
1. Chemical nature: glycoprotein hormones
2. Source: from all the body cells (T –
lymphocytes, monocytes, kidney, liver,
hematopoietic cells)
3. Action: stimulate, regulate and maintain
the blood cells Proliferation,
Differentiation , Maturation and function
16. Haemopoietic growth
factors
These factors have the capacity to stimulate the
proliferation of their target progenitor cells when used
as a sole source of stimulation The most important are
GM-CSF
Granulocyte-Macrophage colony stimulating
factor
M-CSF
Macrophage colony stimulating factor
Erythropoietin (EPO)
Erythropoiesis stimulating hormone
Thrombopoietin (TPO)
Stimulates megakaryopoiesis
17. Cytokines especially for stem cells and lymphocytes
IL 1 (Interleukin 1)
IL 3
IL 4
IL 5
IL 6
IL 9
IL 11
TGF-β
SCF (Stem cell factor, also known as kit-ligand)
===========
Cytokines have no (e.g IL-1) or little (SCF) capacity to
stimulate cell proliferation on their own, but are able
to synergise with other cytokines to recruit nine cells
into proliferation
Haemopoietic growth factors
-
18. Other regulator of blood cells production (
hormones)
a)Androgen
b)Corticosteroid
c)Prostaglanding E2
d)Thyroxin
19. Stem cells and blast cells
Stem cells or Progenitor Cells
1. Source of differentiated cells
2. Originated in the bone marrow
3. Capable to give new cells
4. Regulated by the cytokines or growth factors
Example
• CFU-E (erythrocytes)
• CFU-Meg (megakaryocyte)
• CFU-Eo –Bas (Eosinophil and Basophil)
• CFU-GM (Granular and monocytes
20. Stem cells and blast cells
Blast cells or Precursor Cells
1. Are cells originated in the bone marrow
2. Not capable to give new cells
3. Developing to be mature and function cells
Example :
• Proerythroblast
• Lymphblast,
• Myelocytoblast
• Megakaryoblast
21. Blood Cell Production (Hemopoiesis)
Hemopoietic tissues produce blood cells
The Red bone marrow is the active part of bones
which produce blood cells especially in the first 2
years of the life
Red bone marrow produces RBCs, WBCs and
platelets
Stem cells called hemocytoblasts, multiply
continually and are pluripotent (capable of
differentiating into multiple cell lines)
committed cells are destined to continue down one
specific cell line
Summary